Skip to main content

Table 1 Admission characteristics of diabetic patients by type of HEs(X ± S)

From: Clinical profiles, outcomes and risk factors among type 2 diabetic inpatients with diabetic ketoacidosis and hyperglycemic hyperosmolar state: a hospital-based analysis over a 6-year period

Variables

DKA

HHS

DKA-HHS

Number of patients

65

74

19

Age (years)

53.4 ± 16.5

75.4 ± 11.6 aa

61.9 ± 16.9 c

Gender (male: female)

38:27

26:48

7:12

History of DM (years)

7.01 ± 6.42

8.0 (0.5–10.0)

10.39 ± 9.52

Hospital stay (days)

11.49 ± 5.10

18.32 ± 14.50 aa

11.58 ± 6.57 c

Expenses (Yuan)

8955.3 (6583.5−12,838.1)

14,815.3 (7387.8−20,449.7) aa

10,827.5 ± 5280.5 cc

Mortality (%)

0

21.6

5.3

RBG (mmol/L)

20.64 ± 6.02

34.27 ± 1.78 aa

33.98 ± 0.72bb

HbA1c(%)

11.60 ± 2.58

10.68 ± 2.77

10.86 ± 3.18

Fasting C-peptide (ng/ml)

0.35 (0.12–0.80)

0.95 ± 0.81 a

0.28 (0.09–0.37) c

Arterial PH

7.21 ± 0.10

7.40 ± 0.06 aa

7.15 ± 0.11 cc

SB (mmol/L)

12.82 ± 4.69

23.50 ± 4.55 aa

12.58 ± 7.74 cc

EPO (mOsm/L)

308.82 ± 14.21

383.74 ± 22.12 aa

348.37 ± 31.94 bb, cc

Na+(mmol/L)

135.92 ± 5.67

160.19 ± 8.28 aa

146.05 ± 12.96 bb,cc

BUN (mmol/L)

7.98 ± 5.22

21.01 ± 11.60 aa

14.17 ± 8.38 b,c

Cr (umol/L)

79.0 (60.0–107.50)

151.50 (82.50−218.0) aa

163.16 ± 66.79 bb

  1. Note: DKA vs HHS,a P < 0.05, aa P < 0.01
  2. DKA vs DKA-HHS, b P < 0.05, bb P < 0.01
  3. HHS vs DKA-HHS, c P < 0.05, cc P < 0.01